Agenda/Scientific Program

View the Scientific Program

The 2024 CE Pharm Symposium will bring together industry, academia, and regulatory agencies from around the world to discuss recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals. Speaker presentations, panel discussions, roundtables, and poster sessions will give you the opportunity to engage with fellow attendees in meaningful discussions. We look forward to an informative Symposium and hope to see you there. Be ready to network, collaborate, and expand your knowledge.

Keynote Speaker

Neil L. Kelleher, PhD is the Walter and Mary Glass Professor of Molecular Biosciences and professor of chemistry in the Weinberg College of Arts and Sciences. He also is director of the 50-person Proteomics Center of Excellence, Director of the Chemistry of Life Processes Institute and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 

His research is focused in the areas of top-down proteomics, natural products discovery, and cancer biology. With >450 papers, Kelleher is a cross-disciplinary investigator with international impact in proteomics (the study of proteins).  Together with colleagues in a research consortium (https://www.topdownproteomics.org/), this emerging approach to measure proteins with complete molecular specificity is being advanced to improve the detection and assignment of function to protein modifications and complexes. Now with an H-index of 90, Kelleher has mentored over 52 Ph.D. students, >200 postdoctoral scholars, and >200 undergraduates. After a breakthrough Nature paper in 2011, Kelleher has continued to push the boundaries of proteomics, most recently culminating in a publication in Science (2022, 375: 411-418). Perspectives published by Kelleher and a consortium of like-minded researchers over the last decade articulating the value of proteoforms and a landmark project to map all proteoforms in the human body (Sci. Adv. 2021, 7: eabk0734) typify their thought leadership in a field seeing a new crescendo of interest and activity in the 2020s. This “domestication” of the human proteome via precise compositional mapping will improve the efficiency of basic and clinical research and therefore enhance diverse goals for the 21st Century, including designer organs, personalized medicine, and early detection of human disease. 

A serial entrepreneur, he has spun out successful companies and recently co-founded two new ones. His contributions have been recognized by multiple awards, including the Biemann Medal from the American Society for Mass Spectrometry, the Donald F. Hunt Distinguished Contribution in Proteomics award from the US Human Proteome Organization, the Pfizer Award in Enzyme Chemistry from the American Chemical Society, and a Searle Scholar Award.